Company Announcements - Dameng Data's director and senior vice president is under investigation [1][2] - Dongjie Intelligent will continue to suspend trading from August 22, with an expected suspension period of no more than 3 trading days [1][2] - Tianxiao plans to issue H-shares and list on the Hong Kong Stock Exchange [1][2] - Ganneng Energy intends to transfer 65% equity of Ganneng Lingfeng [1][2] Investment Projects - Lanshi Heavy Industry plans to invest in the construction of supporting facilities for the Xinjiang Lanshi Industrial Park [1][2] - Chende International's Dener Xiangjiang Company plans to invest 15.38 million yuan in an ecological power station project [2] - Lanshi Heavy Industry also plans to invest in enhancing nuclear power equipment production capacity in Qingdao [2] Share Buybacks - China Petroleum plans to repurchase shares with an investment of 500 million to 1 billion yuan [1][2] - Dongbei Group intends to repurchase shares with an investment of 40 million to 80 million yuan [2] Financial Performance - Sany Heavy Industry reported a net profit of 5.216 billion yuan for the first half of the year, a year-on-year increase of 46% [1][3] - StarNet Ruijie reported a net profit of 212 million yuan for the first half of the year, a year-on-year increase of 69.32% [3] - Huadian reported a net profit of 1.683 billion yuan for the first half of the year, a year-on-year increase of 47.5% [3] - GoerTek reported a net profit of 1.417 billion yuan for the first half of the year, a year-on-year increase of 15.65% [3] Shareholding Changes - Yintai Holdings plans to increase its shareholding by 1% to 2% [1][3] - Boji Pharmaceutical's actual controller and associated parties plan to reduce their holdings by no more than 3% [1][3] Strategic Partnerships - Greeenmei signed a strategic cooperation agreement with Weilan Lithium Core for the joint development of ultra-high energy density battery materials [1][3] - Zhenghe Industrial plans to raise no more than 818 million yuan through a private placement for agricultural machinery component expansion projects [1][3]

确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 持有博济医药科技股份有限公司（以下简称"公司"）股份 118,674,370 股 （占公司剔除回购专用证券账户中股份数量后的总股本比例 30.99%）的控股股 东、实际控制人王廷春先生及持有公司股份 5,536,700 股（占公司剔除回购专用 证券账户中股份数量后的总股本比例 1.45%）的一致行动人横琴广金美好基金管 理有限公司－广金美好费米十三号私募证券投资基金（以下简称"费米十三 号"）计划在本公告披露之日起 15 个交易日后的 3 个月内，以大宗交易或集中 竞价的方式合计减持本公司股份不超过 11,486,500 股（占公司剔除回购专用证券 账户中股份数量后的总股本比例的 3.00%）。 公司于近日收到控股股东、实际控制人王廷春先生及其一致行动人费米十三 号出具的《股份减持计划告知函》。现将有关情况公告如下： 证券代码：300404 证券简称：博济医药 公告编号：2025-062 博济医药科技股份有限公司 公司控股股东王廷春先生及其一致行动人横琴广金美好基金管理有限公司 －广 ...

Group 1 - The stock price of Boji Pharmaceutical closed at 11.98 yuan on August 21, 2025, down 3.07% from the previous trading day, with a trading volume of 567 million yuan and a turnover rate of 16.61% [1] - Boji Pharmaceutical operates in the healthcare services industry, with 99.39% of its revenue coming from service-related activities as reported in the 2024 financial report [1] - The controlling shareholder Wang Tingchun and his concerted parties plan to reduce their holdings by no more than 11.4865 million shares, accounting for 3% of the total share capital, due to personal funding needs [1] Group 2 - On August 21, the net outflow of main funds was 18.1492 million yuan, but over the past five days, the overall net inflow of main funds was 139 million yuan [1]

Performance Disclosure - Jishi Media reported a net loss of 232 million yuan in the first half of 2025, with operating revenue of 999.7 million yuan, an increase of 8.7% year-on-year, compared to a net loss of 195 million yuan in the same period last year [1] - Sinopec's operating revenue for the first half of 2025 was 1.41 trillion yuan, a decrease of 10.6% year-on-year, with a net profit attributable to shareholders of 21.483 billion yuan, down 39.8% year-on-year [2] - Baofeng Energy achieved operating revenue of 22.82 billion yuan in the first half of 2025, an increase of 35.05% year-on-year, with a net profit attributable to shareholders of 5.718 billion yuan, up 73.02% year-on-year [3] Shareholding Changes - Zhongyin Securities announced that Jiangxi Copper intends to reduce its stake by no more than 8.334 million shares, representing up to 3% of the company's total share capital [4] - Boji Pharmaceutical's controlling shareholder Wang Tingchun and his concerted parties plan to reduce their holdings by no more than 1.14865 million shares, also up to 3% of the company's total share capital, between September 12, 2025, and December 11, 2025 [5] - Green Island Wind's shareholder, Zhenzhong Investment, intends to reduce its stake by no more than 680,000 shares, which is up to 1% of the company's total share capital [6] Risk Matters - Dameng Data announced that its director and senior vice president Chen Wen is under investigation, but the company's daily operations remain normal and business is progressing steadily [7]

据统计，8月21日，盘后银座股份披露增持情况。包括国脉科技、真视通、吉比特、鸿特科技、同飞股 份、绿岛风、博济医药、探路者、恒邦股份、中银证券在内的10家A股上市公司披露减持情况。 | | | 8.21上市公司盘后增持情况 | | --- | --- | --- | | 1 | 银座股份 | 控股股东拟增持1%-2%公司股份 | | | | 8.21上市公司盘后减持情况 | | 1 | 国脉科技 | 拟出售已回购的1.54%公司股份 | | 2 | 賣视通 | 股东计划减持不超过3%公司股份 | | 3 | 吉比特 | 副董事长陈拓琳拟减持不超过0.3470%公司股份 | | র | 鸡精科技 | 股东吴晓敏计划减持不超过1%的公司股份 | | 5 | 同飞股份 | 股东众和盈计划减持不超过764400股股份 | | 6 | 博济医药 | 控股股东干迁春及其一致行动人拟减持不超过3.00%公司股 | | 7 | 绿岛风 | 股东振中投资计划减持不超过1.00%公司股份 | | 8 | 探路者 | 大股东干静计划减持不超过0.5%公司股份 | | 0 | 中银证券 | 江西铜业拟减持公司不超3%股份 | | 1 ...

恒邦股份：拟择机减持万国黄金不超其总股本的3.69% 银座股份：控股股东山东省商业集团有限公司拟增持1%-2%公司股份 鸿特科技：股东吴晓敏拟减持不超过1%公司股份 探路者：大股东王静拟减持不超过0.5%公司股份 同飞股份：股东众和盈拟减持不超过0.4503%公司股份 吉比特：副董事长陈拓琳拟减持不超过0.3470%公司股份 (本文来自第一财经) 真视通：控股股东之原一致行动人苏州隆越拟减持不超过3%公司股份 中银证券：股东江铜股份拟减持不超3%公司股份 博济医药：控股股东及其一致行动人拟减持不超3%公司股份 绿岛风：股东振中投资拟减持不超1%公司股份 ...

格隆汇8月21日丨博济医药(300404.SZ)公布，持有公司股份118,674,370股(占公司剔除回购专用证券账户 中股份数量后的总股本比例30.99%)的控股股东、实际控制人王廷春先生及持有公司股份5,536,700股(占 公司剔除回购专用证券账户中股份数量后的总股本比例1.45%)的一致行动人横琴广金美好基金管理有限 公司－广金美好费米十三号私募证券投资基金(简称"费米十三号")计划在公告披露之日起15个交易日后 的3个月内，以大宗交易或集中竞价的方式合计减持公司股份不超过11,486,500股(占公司剔除回购专用 证券账户中股份数量后的总股本比例的3.00%)。 ...

Buyback and Shareholder Actions - Sinopec plans to repurchase A-shares with a total fund of no less than RMB 5 billion and no more than RMB 10 billion, potentially reducing its registered capital [1] - Hengbang Mining intends to reduce its stake in the Hong Kong-listed company, WanGuo Gold, by up to 40 million shares, representing approximately 3.69% of WanGuo's total share capital [5] Product Approvals and Market Launches - Wantai Biological's nine-valent HPV vaccine has received the batch release certificate, marking its official market launch and enhancing the company's product lineup [1] - Changchun High-tech's subsidiary has received acceptance for the clinical trial application of GenSci143, a dual-specific antibody drug, which may provide new treatment options for certain tumors [7] Financial Performance - Hongxin Electronics reported a 15.01% increase in revenue to RMB 3.494 billion and a 9.85% rise in net profit to RMB 53.99 million for the first half of 2025 [2] - Sanwei Xinan experienced a net loss of RMB 29.39 million in the first half of 2025, despite a 15.19% increase in revenue to RMB 195 million [3] Corporate Developments - TianTan Bio received a commitment from its controlling shareholder to resolve new competition issues arising from a recent acquisition [4] - Feilu Co. announced a potential change in control, leading to a temporary suspension of its stock trading [8] Investment and Expansion - Jinbei Electric's subsidiary has signed a purchase agreement for a factory in Europe, marking significant progress in establishing its European production base [1] - Shengshi Technology plans to establish a wholly-owned subsidiary to integrate AI and humanoid robot technology with innovative toy products, investing RMB 10 million [6]

Group 1 - The core revenue composition of Boji Pharmaceutical for the year 2024 is 99.39% from services and 0.61% from sales [1] - The controlling shareholder, Wang Tingchun, holds approximately 119 million shares, representing 30.99% of the total share capital after excluding repurchased shares [3] - The company plans to reduce its shares by up to approximately 11.49 million shares, which is 3% of the total share capital after excluding repurchased shares, through block trading or centralized bidding within three months [3]

业绩披露 每经记者｜陈晴 每经编辑｜文多 博济医药：控股股东及其一致行动人拟减持不超公司3%的股份 博济医药公告，控股股东王廷春及一致行动人拟于2025年9月12日至2025年12月11日，通过大宗交易或 集中竞价合计减持不超过1148.65万股公司股份，即不超过公司总股本的3.00%。 吉视传媒：上半年净亏损2.32亿元 吉视传媒公告，2025年上半年营业收入为9.97亿元，同比增长8.70%，归母净利润为亏损2.32亿元，上 年同期公司净亏损1.95亿元。 中国石化：上半年归母净利润为214.83亿元 中国石化公告，2025年上半年营业收入为1.41万亿元，同比下降10.6%，归母净利润为214.83亿元，同 比下降39.8%。 宝丰能源：上半年归母净利润同比增长73.02% 宝丰能源公告，2025年上半年营业收入为228.20亿元，同比增长35.05%，归母净利润为57.18亿元，同 比增长73.02%。 增减持 中银证券：江西铜业拟减持不超公司3%的股份 中银证券公告，截至公告披露日，股东江西铜业持有公司1.3亿股，占公司总股本的4.70%；因自身经营 发展需要，拟合计减持不超过8334万股，即不超公 ...